Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum

Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial. As an analyst tracking small-cap biotech names, Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL ) has always been one of my favorites, thanks to the company's evolution from a TAVALISSE-centric company to a hematologic biotech that has multiple He is the lead ...